European stocks fell as President Donald Trump’s latest tariff moves sowed fresh confusion over the outlook for global trade. Shares in Novo Nordisk A/S slumped after its next-generation obesity shot drug fell short of Eli Lilly & Co.’s rival blockbuster in a trial.